HIGHLIGHTS
- who: Laura van Wijk from the Between January , and December, all consecutive patients who underwent pancreatic resection and were pathologically diagnosed with PDAC at the University Medical Centre Groningen, the Netherlands, or the Isala clinics, the Netherlands, were included in the present studyAll medical records were retrospectively reviewed. Patients were excluded if data relating to their preoperative CRP or albumin were missing or if they already had metastatic disease at the time of resection. All patients were followed up until October , or death. Survival status was assured using the national Personal Records Database. This study was approved . . .

If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.